US2021041470A1
|
|
Functional ligands to opioids and opioid metabolites
|
US2020172906A1
|
|
Functional ligands to LL37
|
EP3787406A1
|
|
Functional ligands to dicamba
|
US2019242030A1
|
|
Methods and materials for multiplexed collections of functional ligands
|
CA3031696A1
|
|
Functional ligands to biocides
|
WO2019094968A1
|
|
Detection of tenofovir
|
WO2018237074A1
|
|
Functional ligands to target molecules
|
US2019017101A1
|
|
Functional ligands to THC
|
US2019092817A1
|
|
Functional ligands to peptides
|
WO2018160762A1
|
|
Functional ligands to drug compounds
|
US2019382766A1
|
|
Functional ligands to drug compounds
|
WO2018156806A1
|
|
Functional ligands to target molecules
|
US2018237782A1
|
|
Functional ligands to target molecules
|
US2018179540A1
|
|
Functional ligands to opioids and opioid metabolites
|
US2018066264A1
|
|
Functional ligands to thc
|
US2018100152A1
|
|
Functional ligands to chikungunya envelope proteins
|
US2018030447A1
|
|
Functional ligands to ricin
|
US2018099996A1
|
|
Functional ligands to phthatates
|
US2017233738A1
|
|
Functional ligands to nerve agent metabolites
|
US2019112605A1
|
|
Functional ligands to igg
|